SMOX and bronchiectasis: In healthy controls, mild and severe bronchiectasis, LXA4 was able to significantly improve phagocytosis (comparing only the high MFLI and not total phagocytosis) (figure 5A) and killing of GFP–PAO1 in a concentration-dependent manner with statistical significance achieved at 100 nM LXA4 (figure 5B).